Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.66 USD | -0.92% | +6.10% | +38.28% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.28% | 6.54B | |
+44.48% | 55.07B | |
+44.42% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Needham Adjusts Revolution Medicines' Price Target to $46 From $36, Keeps Buy Rating